Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on PAC 14028. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106660949B reveals a safe, scalable chiral resolution method for TRPV1 antagonist intermediates, offering significant cost reduction in API manufacturing.